Dna X (SONM) Other Accumulated Expenses (2018 - 2023)

Dna X has reported Other Accumulated Expenses for 6 years, with the latest figure at $260000.0 in Q3 2023.

• For the quarter ending Q3 2023, Other Accumulated Expenses rose 182.61% year-over-year to $260000.0; the trailing twelve-month figure through Sep 2023 stood at $260000.0 (up 182.61% YoY), and the FY2022 full-year result was $171000.0, down 49.85% from the prior year.
• Other Accumulated Expenses for Q3 2023 stood at $260000.0, up from $166000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $851000.0 in Q4 2019, with the low at $16000.0 in Q1 2023.
• Historically, Other Accumulated Expenses has averaged $293000.0 across 5 years, with a median of $228000.0 in 2022.
• The largest YoY upside for Other Accumulated Expenses was 182.61% in 2023 against a maximum downside of 94.63% in 2023.
• Dna X's Other Accumulated Expenses stood at $851000.0 in 2019, then slumped by 36.66% to $539000.0 in 2020, then slumped by 36.73% to $341000.0 in 2021, then plunged by 49.85% to $171000.0 in 2022, then jumped by 52.05% to $260000.0 in 2023.
• The last three Other Accumulated Expenses figures came in at $260000.0 (Q3 2023), $166000.0 (Q2 2023), and $16000.0 (Q1 2023), per Business Quant data.